Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy

Fig. 1

Comparisons of SUVmax of breast with pathological characteristics: (upper) P values are 0.039, 0.718, 0.012, and 0.080 for ER, PR, Ki67%, and molecular subtype, respectively. (lower) P values are 0.963, 0.500, 0.629, and 0.198 for cT, cN, cS, and pCR, respectively. Mean values of pSUVmax are indicated and the error bars represent the 95% confidence interval for the mean

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us